Inserm, UMR-946, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France.
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
J Allergy Clin Immunol. 2016 Oct;138(4):1071-1080. doi: 10.1016/j.jaci.2016.03.018. Epub 2016 Apr 6.
Asthma is a heterogeneous disease in which age of onset plays an important role.
We sought to identify the genetic variants associated with time to asthma onset (TAO).
We conducted a large-scale meta-analysis of 9 genome-wide association studies of TAO (total of 5462 asthmatic patients with a broad range of age of asthma onset and 8424 control subjects of European ancestry) performed by using survival analysis techniques.
We detected 5 regions associated with TAO at the genome-wide significant level (P < 5 × 10). We evidenced a new locus in the 16q12 region (near cylindromatosis turban tumor syndrome gene [CYLD]) and confirmed 4 asthma risk regions: 2q12 (IL-1 receptor-like 1 [IL1RL1]), 6p21 (HLA-DQA1), 9p24 (IL33), and 17q12-q21 (zona pellucida binding protein 2 [ZPBP2]-gasdermin A [GSDMA]). Conditional analyses identified 2 distinct signals at 9p24 (both upstream of IL33) and 17q12-q21 (near ZPBP2 and within GSDMA). Together, these 7 distinct loci explained 6.0% of the variance in TAO. In addition, we showed that genetic variants at 9p24 and 17q12-q21 were strongly associated with an earlier onset of childhood asthma (P ≤ .002), whereas the 16q12 single nucleotide polymorphism was associated with later asthma onset (P = .04). A high burden of disease risk alleles at these loci was associated with earlier age of asthma onset (4 vs 9-12 years, P = 10).
The new susceptibility region for TAO at 16q12 harbors variants that correlate with the expression of CYLD and nucleotide-binding oligomerization domain 2 (NOD2), 2 strong candidates for asthma. This study demonstrates that incorporating the variability of age of asthma onset in asthma modeling is a helpful approach in the search for disease susceptibility genes.
哮喘是一种异质性疾病,其发病年龄起着重要作用。
我们旨在确定与哮喘发病时间(TAO)相关的遗传变异。
我们采用生存分析技术,对 9 项 TAO 的全基因组关联研究(共包括 5462 名发病年龄范围广泛的哮喘患者和 8424 名欧洲血统的对照者)进行了大规模的荟萃分析。
我们在全基因组显著水平(P<5×10)检测到 5 个与 TAO 相关的区域。我们在 16q12 区域(靠近圆柱瘤综合征颅顶肿瘤综合征基因[CYLD])发现了一个新的基因座,并证实了 4 个哮喘风险区域:2q12(白细胞介素 1 受体样 1[IL1RL1])、6p21(HLA-DQA1)、9p24(白细胞介素 33)和 17q12-q21(透明带结合蛋白 2[ZPBP2]-gasdermin A[GSDMA])。条件分析确定了 9p24(均位于 IL33 上游)和 17q12-q21(靠近 ZPBP2 且位于 GSDMA 内)的 2 个不同信号。这 7 个不同的基因座共同解释了 TAO 变异性的 6.0%。此外,我们表明,9p24 和 17q12-q21 上的遗传变异与儿童哮喘发病年龄较早(P≤.002)密切相关,而 16q12 单核苷酸多态性与哮喘发病较晚(P=.04)相关。这些基因座上疾病风险等位基因的高负担与哮喘发病年龄较早(4 岁与 9-12 岁,P=10)相关。
16q12 新的 TAO 易感性区域包含与 CYLD 和核苷酸结合寡聚化结构域 2(NOD2)表达相关的变异,NOD2 是哮喘的 2 个重要候选基因。本研究表明,在寻找疾病易感基因时,将哮喘发病年龄的可变性纳入哮喘建模是一种有用的方法。